TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes

During treatment , contact your healthcare provider if you experience: Severe or persistent abdominal pain , particularly if radiating to the back, which could indicate pancreatitis Neck swelling or lump , difficulty swallowing, or persistent hoarseness Worsening symptoms of your autoimmune condition, such as increased joint pain, rashes, or fatigue Severe gastrointestinal symptoms including persistent vomiting or diarrhoea, which may lead to dehydration and affect kidney function Signs of hypoglycaemia (low blood sugar), especially if taking Ozempic with insulin or sulfonylureas Visual changes or symptoms suggesting diabetic retinopathy progression Signs of severe allergic reaction such as swelling of the face, lips, tongue, or throat, breathing difficulties, or severe rash (seek urgent medical attention) Regular monitoring is crucial
Suddenly there's huge awareness, whether on social media, talking to neighbors or watching TV
Starting at higher body weight If you are beginning your GLP-1 protocol at a higher body weight, you likely have ample subcutaneous tissue at all three injection sites
At the Florida Surgery & Weight Loss Center , our expertise is accessible to you across Maryland via secure, licensed telehealth services